Ezekowitz Alan

SEC Form 4 insider trading activity

Ezekowitz Alan has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Jun 30, 2026.

On the most recent filing, Ezekowitz Alan is listed as Director at Fulcrum Therapeutics, Inc. Inside the rolling window, Ezekowitz Alan reported no open-market purchases and 1 open-market sale totaling $66K in FULC.

Companies traded

Other insiders at FULC

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$66K

reported sales (SEC code S)

Companies

1

in the rolling window

Source
FULC
Ezekowitz Alan
Sale$66KJun 30SEC ↗
Showing 1–1 of 1
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Ezekowitz Alan made?

Ezekowitz Alan has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company since 2026.

Which companies does Ezekowitz Alan trade?

Ezekowitz Alan has filed SEC Form 4 disclosures for 1 company, including FULC.

When was Ezekowitz Alan's most recent SEC Form 4 filing?

Ezekowitz Alan's most recent SEC Form 4 filing on Tracefour is dated Jun 30, 2026.

What is Ezekowitz Alan's total buy and sell value in the current window?

Inside the rolling retention window, Ezekowitz Alan bought $0 and sold $66K based on SEC Form 4 filings.

What was Ezekowitz Alan's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 18,000 FULC shares on 2026-06-26, worth $66K, per SEC Form 4 filings.